Genomic Health Inc. (GHDX) Climbed 5.08% or 1.6 To Price $33.11 On Friday


Genomic Health Inc. (GHDX) climbed 5.08% or 1.6 to $33.11. It is around 333558 shares traded, which is 150.82% compare to the average total volume 221161. The market cap of GHDX is $1.15 billion. The year to date change is -8.8%. The 52 week price range is from $26.54 to $37.5. Price of GHDX have changed -1.35% during last week. N/A 5.63% over last 3 months, 0.22% over last 6 months and 0.41% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GHDX is 33.66. It is 1.66% above current price. The 200-day Moving Averages for GHDX is 32.15. It is -2.90% below current price. The 52-week High is 37.5. It is 13.26% from the current price. The 52-week Low is 26.54. It is -19.84% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GHDX is 3.8 on 2018-02-15. Short % to float is 2.04%. There are some statistics of GHDX. It is has market cap $1.15 billion. The share outstanding is 34.79 million. The average volume is 221161. The revenue is 336.03M. The gross profit is 283.04M. The percent of top 15 Institution holding is 66.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GHDX is -2.69%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GHDX is -2.07%.


Tags:

Share this post